Dr. Amalia Gastaldelli

Dr. Amalia Gastaldelli is the Research Director of the Cardiometabolic Risk Laboratory at the Institute of Clinical Physiology (IFC) of CNR of Pisa, Italy, as well as an Adjunct Professor at the Division of Diabetes of the University of Texas Health Science Center, San Antonio, TX, USA (since 2006), and the Scuola Superiore S. Anna in Pisa (since 2017). She earned her  PhD in Human Physiology from the University of Texas Medical Branch in 1997. She was the principal investigator in many international projects most of which on liver metabolism, like the project “Effect of Exenatide on Brain, Adipose Tissue, Pancreas, and Liver Function”, the EU-FP7 FLIP (Fatty Liver Inhibition of Progression), the H2020 EPOS (Elucidating Pathways of Steatohepatitis), one H2020 Marie Curie ETN program for the training of international students (FOIE GRAS) and two Marie Curie RISE for the staff exchange (MAST4HEALTH and mtFOIEGRAS) and the IMI2-LITMUS on the discovery of biomarkers of NAFLD. She is also collaborating with many institutions in Europe and the United States, participating in local grants as a foreign partner. She has more than 25 years of experience in leading national and international scientific projects investigating the pathophysiological mechanisms leading to metabolic diseases, including obesity, non-alcoholic fatty liver disease (NAFLD), and type 2 diabetes.